{
  "trial_id": "NCT03946657",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "American Society of Anaesthesiologists (ASA) physical status class II-III",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "BMI of \u2265 35 kg/m2",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "exclusion": [
    {
      "criterion": "Patients with preexisting cerebrovascular diseases",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "Overt neurological signs",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "Alcohol or psychoactive drug addiction",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "notes": "Patient has been treating with corticosteroid and cyclophosphamides since 4 months ago. His Birmingham Vasculitis Activity Score (BVAS) is above 4.",
  "_meta": {
    "topic_id": "54",
    "trial_id": "NCT03946657",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}